At Shanghai Biotecan Pharmaceuticals Co. Ltd. (BIOTECAN, Stock No. 835720), our mission is to provide the best healthcare services through the most advanced technology. The company’s goal is to empower every medical professional and patient with specific knowledge to properly treat and prescribe patients symptoms and conditions through precision medicine. Biotecan uses strict quality management control system and strictly follows China’s GLP (Good Laboratory Practice of Drugs) standards. The company has International CAP Certification, and China’s Genetic Clinical Laboratory Certification (PCR). Biotecan has an unparalleled team of experts from around the world in molecular diagnostics, medical big data, technology, engineering, and commercial development, making us a pioneer in precision medicine. Biotecan was founded in 2008, and currently owns 17 subsidiaries